Set Measure ID | Measure Short Name |
---|---|
CSTK-01 | National Institutes of Health Stroke Scale (NIHSS Score Performed for Ischemic Stroke Patients) |
CSTK-02 | Modified Rankin Score (mRS at 90 Days) |
CSTK-03 | Severity Measurement Performed for SAH and ICH Patients (Overall Rate) |
CSTK-04 | Procoagulant Reversal Agent Initiation for Intracerebral Hemorrhage (ICH ) |
CSTK-05 | Hemorrhagic Transformation (Overall Rate) |
CSTK-06 | Nimodipine Treatment Administered |
CSTK-07 | Median Time to Revascularization |
CSTK-08 | Thrombolysis in Cerebral Infarction (TICI Post-Treatment Reperfusion Grade) |
CSTK-09 | Arrival Time to Skin Puncture (Overall Rate) |
CSTK-10 | Modified Rankin Score (mRS at 90 Days: Favorable Outcome) |
CSTK-11 | Rate of Rapid Effective Reperfusion From Hospital Arrival |
CSTK-12 | Rate of Rapid Effective Reperfusion From Skin Puncture |
Element Name | Collected For |
---|---|
Admission Date | All Records, |
Birthdate | All Records, |
Discharge Date | All Records, Not collected for HBIPS-2 and HBIPS-3 |
Hispanic Ethnicity | All Records, |
ICD-10-CM Other Diagnosis Codes | All Records, Optional for HBIPS-2, HBIPS-3 |
ICD-10-CM Principal Diagnosis Code | All Records, Optional for HBIPS-2, HBIPS-3 |
ICD-10-PCS Other Procedure Codes | All Records, Optional for All HBIPS Records |
ICD-10-PCS Other Procedure Dates | All Records, Optional for All HBIPS Records |
ICD-10-PCS Principal Procedure Code | All Records, Optional for All HBIPS Records |
ICD-10-PCS Principal Procedure Date | All Records, Optional for All HBIPS Records |
Measure Category Assignment | All Records, Calculation, Used in calculation of the Joint Commission's aggregate data. |
Payment Source | All Records, Optional for HBIPS-2 and HBIPS-3 |
Race | All Records, |
Sex | All Records, |
Element Name | Collected For |
---|---|
Measure Category Assignment | All Records, Calculation |
Measurement Value | Calculation |
The CSTK Initial Patient Population is unique in that it is comprised of three distinct subpopulations: ischemic stroke patients who do not undergo a reperfusion therapy (i.e., procedure), ischemic stroke patients who undergo a reperfusion therapy (IV t-PA, IA t-PA, or mechanical endovascular reperfusion (MER) therapy), and hemorrhagic stroke patients.
Ischemic StrokePatients admitted to the hospital for inpatient acute care are included in the CSTK 1-Ischemic Stroke Without Procedure subpopulation sampling group if they have: ICD-10-CM Principal Diagnosis Code as defined in Appendix A, Table 8.1, a Patient Age (Admission Date – Birthdate) ≥ 18 years and a Length of Stay (Discharge Date - Admission Date) ≤ 120 days.
Note: Hospitals are NOT required to sample their data. If sampling offers minimal benefit (e.g., a hospital has 45 cases for the quarter and must select a sample of 42 cases), the hospital may choose to use all cases. Ischemic Stroke With IV t-PA, IA t-PA, or MERPatients admitted to the hospital for inpatient acute care are included in the CSTK-2 Ischemic Stroke With IV t-PA, IA t-PA, or MER subpopulation sampling group if they have: ICD-10-CM Principal Diagnosis Code as defined in Appendix A, Table 8.1 AND ICD-10-PCS Principal or Other Procedure Codes as defined in Appendix A, Table 8.1a OR Table 8.1b, a Patient Age (Admission Date – Birthdate) ≥ 18 years and a Length of Stay (Discharge Date - Admission Date) ≤ 120 days.
Note: Hospitals are NOT required to sample their data. If sampling offers minimal benefit (e.g., a hospital has 45 cases for the quarter and must select a sample of 42 cases), the hospital may choose to use all cases. Hemorrhagic StrokePatients admitted to the hospital for inpatient acute care are included in the CSTK 3-Hemorrhagic Stroke subpopulation sampling group if they have: ICD-10-CM Principal Diagnosis Code as defined in Appendix A, Table 8.2, a Patient Age (Admission Date – Birthdate) ≥ 18 years and a Length of Stay (Discharge Date - Admission Date) ≤ 120 days.
Note: Hospitals are NOT required to sample their data. If sampling offers minimal benefit (e.g., a hospital has 80 cases for the quarter and must select a sample of 75 cases), the hospital may choose to use all cases.Hospitals that choose to sample have the option of sampling quarterly or sampling monthly. A hospital may choose to use a larger sample size than is required. Hospitals whose Initial Patient Population size is less than the minimum number of cases per quarter for the measure set cannot sample.
Regardless of the option used, hospital samples must be monitored to ensure that sampling procedures consistently produce statistically valid and useful data. Due to exclusions, hospitals selecting sample cases MUST submit AT LEAST the minimum required sample size.
The following sample size tables for each option automatically build in the number of cases needed to obtain the required sample sizes. For information concerning how to perform sampling, refer to the Population and Sampling Specifications section in this manual.
Average Quarterly Initial Patient Population Size "N" |
Minimum Required Sample Size "n" |
---|---|
> 420 | 84 |
211-419 | 20% of Patient Population size |
43-210 | 42 |
≤ 42 | No sampling; 100% Patient Population required |
Average Quarterly Initial Patient Population Size "N" |
Minimum Required Sample Size "n" |
---|---|
> 420 | 84 |
211-419 | 20% of Patient Population size |
43-210 | 42 |
≤ 42 | No sampling; 100% Patient Population required |
Average Quarterly Initial Patient Population Size "N" |
Minimum Required Sample Size "n" |
---|---|
> 750 | 150 |
376-750 | 20% of Patient Population size |
76-375 | 75 |
≤ 75 | No sampling; 100% Patient Population required |
Average Monthly Initial Patient Population Size "N" |
Minimum Required Sample Size "n" |
---|---|
> 140 | 28 |
71-140 | 20% of Patient Population size |
15-70 | 14 |
≤ 14 | No sampling; 100% Patient Population required |
Average Monthly Initial Patient Population Size "N" |
Minimum Required Sample Size "n" |
---|---|
> 140 | 28 |
71-140 | 20% of Patient Population size |
15-70 | 14 |
≤ 14 | No sampling; 100% Patient Population required |
Average Monthly Initial Patient Population Size "N" |
Minimum Required Sample Size "n" |
---|---|
> 250 | 50 |
126-250 | 20% of Patient Population size |
26-125 | 25 |
≤ 25 | No sampling; 100% Patient Population required |
CPT® only copyright 2022 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.
You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.
U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.
Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.
This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.
Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.